Piper Sandler Rates CNTB buy, $7 Price Target

Piper Sandler reaffirmed its buy rating for CNTB, targeting a price of $7, a 194.12% upside from the current price.

By EarningsIQ Research Desk · Published Jun 26, 2026, 10:01 AM EDT · Updated Jun 30, 2026, 12:02 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Piper Sandler rated CNTB ($CNTB) "buy" with a $7 price target on June 26, 2026.

Since the rating, $CNTB is up 7.8% after 1 week, down 4.1% after 1 month and down 58.5% to date (from the $2.19 close on Jun 26, 2026).

CNTB CNTB

$0.91 -63.89% year to date

Daily close · Oct 16, 2026

Key Points

Piper Sandler reaffirmed a buy rating on CNTB with a $7 price target as of June 26, 2026.
Piper Sandler's $7 price target implies 194.12% upside from CNTB's ($CNTB) current $2.38 share price.
CNTB shares were trading at $2.07 on Friday, with peers like Ikarian Capital increasing their holdings by 12.5%.
Analyst activity includes HC Wainwright reiterating a $7 target and Canaccord Genuity initiating at $6.

Get $CNTB trade alerts by text

We text you when insiders, Congress or big funds trade $CNTB. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CNTB alert may contain errors. Disclosures

Piper Sandler recently reiterated its buy rating on CNTB, setting a price target of $7. This update came from analyst Biren Amin on June 26, 2026. Shares of CNTB traded at $2.07 on Friday.

Analyst rating track record

Piper Sandler vs. the S&P 500

YTD return -14.23% hypothetical

All-time return +28.29% S&P 500 +34.03%

vs. S&P 500 -5.74% behind the index

Hypothetical returns from Piper Sandler's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in CNTB

Ikarian Capital, LLC grew its holdings in CNTB by 600,000 shares, ending with 5,388,486 shares valued at about $13.1 million, marking a 12.5% increase. Boothbay Fund Management, LLC kept its position steady with 1,234,582 shares worth approximately $3.2 million. 683 Capital Management, LLC opened a new position with 900,000 shares valued at $2.36 million. Perceptive Advisors LLC maintained its stake at 792,696 shares, worth around $2.08 million. Richmond Brothers, Inc. increased its holdings by 303,099 shares, reaching 476,584 shares valued at about $1.25 million, reflecting a 174.7% increase.

CNTB Stock Snapshot

Shares of CNTB traded at $2.07 as of Friday. While specific market cap and P/E ratios are not available, the stock has seen significant activity from both institutional investors and analysts.

12-month forecast

$CNTB price target

CNTB daily closes and this analyst's $7 target. Not advice.

Insider Buying and Selling at CNTB

Several insiders have been active in CNTB recently. On May 29, 2026, James Huang purchased 150,000 shares at an average price of $2.48. Earlier, on March 31, 2026, Jean Liu and Kleanthis Gabriel Xanthopoulos acquired 5,061 and 2,816 shares respectively, though the price for these transactions was not disclosed. Conversely, Panacea Innovation Limited sold 2,000,000 shares at $3.00 on November 24, 2025.

Analysts Set New Price Targets

On June 26, 2026, Piper Sandler reiterated its buy rating for CNTB with a $7 price target. The day before, HC Wainwright & Co. also reaffirmed a buy rating with the same target price. Earlier, Canaccord Genuity initiated coverage with a buy rating and a $6 target on May 26, 2026. Cantor Fitzgerald followed with a buy rating and a $4 target on May 21, 2026.

Bottom Line

Piper Sandler's reaffirmation of a buy rating for CNTB with a $7 target reflects ongoing confidence in the company's prospects. Institutional investors have been actively adjusting their positions, indicating varying levels of confidence. The reiteration by multiple analysts suggests that CNTB remains on the radar for potential growth, although 13F filings and analyst reports are backward-looking and may not reflect current positions or sentiments.